SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 8, 2026

STE

STERIS plc
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $966K total
Actionable Insight • Neutral

No actionable bearish signal from this cluster. CEO selling at ~0.006% market cap is routine diversification. Monitor the next quarterly filing (Form 4/10-Q) for any acceleration or broadening of C-suite sales volume, but no near-term catalyst is implied. The broad equity grants on June 2 suggest normal compensation cycles, not distress.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$212.88
T+0 close · Jun 8, 2026 · via day close
Latest settled
+8.08%
T+60 · $230.08
Vs SPY
+4.27%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 9 $212.88entry
  2. T+1 · 5mo ago −2.25%α −0.67% · $208.10
  3. T+5 · 5mo ago −3.26%α −5.68% · $205.93
  4. T+20 · 4mo ago +1.18%α −0.27% · $215.39
  5. T+60 · 3mo ago +8.08%α +4.27% · $230.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares over a 5-day window (May 28–June 4), while a separate cluster filing shows Carestio also sold an additional $291K on June 5. Tax-withholding and equity-grant transactions by multiple executives (Burton, Fraser, Kohler, Zangerle, Madsen, Tamaro, Boulud) are non-cash events with no economic signal. The open-market sales total ~0.005% of STE's $20.7B market cap, well below the 0.1% threshold for materiality, and CEO selling is not accompanied by broad C-suite or director selling (only 2 insiders). The sales are likely routine diversification rather than an informed negative signal.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
3

Key Facts

  • CEO Daniel Carestio sold $947K open-market (June 4-5, $212-$215 range), plus $291K on June 5 per separate filing
  • Director Richard Breeden sold $310K open-market on June 2 at $209.51
  • Total open-market cash-out: ~$1.26M across 3 insiders; ~0.006% of $20.7B market cap
  • Multiple executives (CFO, SVP, etc.) had non-cash tax-withholding and equity-grant transactions, no economic signal

Financial Impact

Total open-market sales of ~$1.26M against $20.7B market cap; no material economic impact or change in ownership structure

insider ownershipfloat-adjusted dilution

Risk Factors

  • CEO continued selling in subsequent periods could signal waning conviction; watch next 10-Q for revenue/earnings trajectory
  • Sector headwinds in surgical supplies/margin pressure could emerge without insider trading as a leading indicator

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-STE-1780950733972

US Market Status

Market Closed · Opens Thu (12h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026